Medical Compositions for Intravesical Treatment of Bladder Cancer
AssigneeSpectrum Pharmaceuticals, Inc.
InventorsBastiaan Nuijen, Ernie Pfadenhauer, Jos H. Beijnen
Life of this patent
Estimating the term…
Abstract
Anti-cancer coating compositions comprising 3-hydroxymethyl-5-aziridinyl-1-1-methyl-2-[1H-indole-4,7-dione]propenol (E09) are disclosed. More specifically, the coating compositions comprise EO9 and a formulation vehicle. The formulation vehicle improves the solubility and stability of EO9. Additionally, the coating compositions can include coating agents that provide better adhesion of the coating composition to the bladder wall during intravesical delivery of the coating composition.
Claims7
A drug delivery system comprising EO9 and propylene glycol, wherein the drug delivery system is configured to administer the EO9 and the propylene glycol to the bladder via intravesical administration.
A composition comprising about 0.5 mg to about 16 mg of EO9, propylene glycol, sodium bicarbonate, and EDTA.
Dependencies are inferred from the claim text.